Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities
Global professional services firm ZS has been selected by leading biopharmaceutical company Bristol Myers Squibb (BMS) (NYSE: BMY) to support its worldwide commercial analytics organization. This agreement builds on and expands the existing, successful partnership that BMS and ZS created in 2015.
“We look forward to continuing to serve BMS. It is an honor to help one of the most innovative biopharmaceutical companies in the world transform its analytics capabilities and drive business impact.” said Jaideep Bajaj, chairman of ZS.
The work will support BMS’s Business Insights & Analytics (BIA) group—a global, centralized organization that helps drive business success for all markets and business units across BMS through the appropriate use of data. The scope encompasses areas such as data science, marketing mix, forecasting, business development and brand analytics for more than 65 markets.
“For more than 30 years, BMS and ZS have worked together to solve business challenges and deliver organization-wide impact,” said Rohan Fernando, ZS’s client service lead for BMS. “We are thrilled to continue that partnership and help BMS innovate and drive fact-based decision-making that ultimately helps improve patient outcomes.”
ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 10,000-plus ZSers in more than 25 offices worldwide, we are passionately committed to helping companies and their customers thrive. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ALTASCIENCES/VIRPAX21.1.2022 17:02:12 CET | Press release
Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee
OMRON-HEALTHCARE21.1.2022 16:23:07 CET | Press release
OMRON Healthcare Remote Patient Monitoring Services Win “Best of” Honors at CES 2022
TX-SCHLUMBERGER21.1.2022 12:52:13 CET | Press release
Schlumberger Announces Fourth-Quarter and Full-Year 2021 Results
ZULUTRADE21.1.2022 12:10:13 CET | Press release
ZuluTrade - World’s Largest Social Trading Platform Joins the Finvasia Group
IPSEN21.1.2022 07:02:10 CET | Press release
Ipsen Nominates Karen Witts as New Independent Board Member
PROMPERÚ21.1.2022 02:50:06 CET | Press release
Peru Is Presenting Itself at FITUR 2022 as a Bio-safe Destination, Committed to Outdoor Experiences
CA-MCAFEE21.1.2022 02:42:04 CET | Press release
McAfee Continues to Provide Leading Online Protection to Consumers
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom